Document Detail

Perioperative anticholinergic medications and risk of catheterization after urogynecologic surgery.
MedLine Citation:
PMID:  24763158     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: This study aimed to examine how anticholinergic medication exposure affects the risk of failed postoperative void trial (VT) in women undergoing urogynecologic surgery.
METHODS: We conducted a retrospective cohort study of women undergoing outpatient prolapse or incontinence surgery. We evaluated perioperative anticholinergic exposure via the validated anticholinergic risk scale (ARS). Total ARS score was calculated by summing the individual ARS for each medication used during the following periods: at home before surgery, in preoperative holding, intraoperatively, and in postoperative recovery. The "low anticholinergic exposure" cohort (total ARS, ≤7) was compared to the "high anticholinergic exposure" cohort (total ARS, ≥8) to assess our primary outcome: failed postoperative VT on day of surgery.
RESULTS: Of 125 women in the study, 98 (78%) had low anticholinergic exposure and 27 (22%) had high anticholinergic exposure. Overall, 28 (22%) patients failed the postoperative VT. Women in the high anticholinergic group had a significantly higher risk of a failed VT (41% vs 17%, P = 0.01 for high vs low anticholinergic groups, respectively). In logistic regression analysis, adjusting for age, body mass index, diabetes, midurethral sling and anterior repair, high anticholinergic exposure (AOR, 4.15; 95% confidence interval, 1.49-11.57), and anterior repair (AOR, 3.15; 95% CI, 1.15-8.61) remained significantly associated with failed postoperative VT.
CONCLUSIONS: Higher exposure to perioperative anticholinergic medications increases the risk of a failed postoperative VT after outpatient urogynecologic surgery.
Paige J Walter; Alexis A Dieter; Nazema Y Siddiqui; Alison C Weidner; Jennifer M Wu
Related Documents :
24721618 - The effect of differing gleason scores at biopsy on the odds of upgrading and the risk ...
24653858 - C-reactive protein: clinical and epidemiological perspectives.
24486308 - What is the most bothersome lower urinary tract symptom? individual- and population-lev...
23765098 - What is the benefit of screening for thyroid function in pregnant women in the detectio...
9539188 - Differences in resting metabolic rates of inactive obese african-american and caucasian...
15994688 - Psychosocial and psychological interventions for prevention of postnatal depression: sy...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Female pelvic medicine & reconstructive surgery     Volume:  20     ISSN:  2154-4212     ISO Abbreviation:  Female Pelvic Med Reconstr Surg     Publication Date:    2014 May-Jun
Date Detail:
Created Date:  2014-04-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101528690     Medline TA:  Female Pelvic Med Reconstr Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  163-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A Preliminary Evaluation of the TOPAS System for the Treatment of Fecal Incontinence in Women.
Next Document:  Cost-utility of routine endometrial evaluation before le fort colpocleisis.